Background: In spite of technical advances in conventional morphologic
al imaging, these techniques cannot assess biological characteristics
of a tumour. By contrast, positron emission tomography (PET) provides
quantitative metabolic information of tumour and normal tissues. Altho
ugh PET has demonstrated its value for diagnosis and follow-up of diff
erent tumours, reliable quantitative data on tumour metabolism and per
fusion are still limited. Patients and Methods: 25 patients with untre
ated and histologically proven head and neck cancer were investigated
with dynamic PET. Standardised uptake values of 18F-fluorodeoxyglucose
(FDG) and O-15-labelled water were calculated for tumour, lymph node
metastases, soft tissue and blood vessels. Results: Lymph node metasta
ses and tumour tissue revealed markedly FDG metabolism and perfusion.
By contrast, there was only moderate uptake of FDG and O-15-labelled w
ater in soft tissue. Standardised uptake values measured in tumours us
ually proved higher than the values calculated for any other tissue. C
onclusion: These findings underline that PET can be used to compare an
d distinguish different tissues in cancer patients quantitatively. A r
eliable distinction between tumour tissue, lymph nodes and soft tissue
can be based on the characteristic changes in the uptake values of th
ese tissues within the measurement sequence.